Twist Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Twist Bioscience 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. 

CEO
Emily Marine Leproust
CEOEmily Marine Leproust
Employees
979
Employees979
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2013
Founded2013
Employees
979
Employees979

TWST Key Statistics

Market cap
3.52B
Market cap3.52B
Price-Earnings ratio
-45.05
Price-Earnings ratio-45.05
Dividend yield
Dividend yield
Average volume
1.20M
Average volume1.20M
High today
High today
Low today
Low today
Open price
$50.96
Open price$50.96
Volume
0.00
Volume0.00
52 Week high
$59.00
52 Week high$59.00
52 Week low
$23.30
52 Week low$23.30

Stock Snapshot

Twist Bioscience(TWST) stock is priced at $55.92, giving the company a market capitalization of 3.52B. It carries a P/E multiple of -45.05.

During the trading day, Twist Bioscience(TWST) stock saw an opening price of $50.96, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 1.2M.

Over the past 52 weeks, Twist Bioscience(TWST) stock has traded between a high of $59.00 and a low of $23.30.

Over the past 52 weeks, Twist Bioscience(TWST) stock has traded between a high of $59.00 and a low of $23.30.

TWST News

Simply Wall St 2d
A Look At Twist Bioscience Valuation After Strong Results Guidance Raise And Analyst Optimism

Twist Bioscience (TWST) is back in focus after reporting strong quarterly results with year over year revenue growth and a higher full year revenue outlook. At...

A Look At Twist Bioscience Valuation After Strong Results Guidance Raise And Analyst Optimism
Simply Wall St 5d
How Upgraded Guidance And Breakeven Path At Twist Bioscience Has Changed Its Investment Story

In early April 2026, Twist Bioscience reported strong fiscal first‑quarter results and raised its full‑year 2026 revenue guidance, while also outlining a path t...

How Upgraded Guidance And Breakeven Path At Twist Bioscience Has Changed Its Investment Story

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
10%
Sell
0%

People also own

Based on the portfolios of people who own TWST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.